On the dose-effect relationship in the therapy with piracetam (author's transl).
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/786310
Conclusion of this study
The effect of piracetam therapy with different dosages was studied in a double blind trial against placebo on its effect in psychoorganic syndrome of old age. 78 patients (61 females, 17 males) on the average of 73.2 years, showed statistically significant differences between piracetam therapy at a dosage of 3 X 1600 mg per day und placebo after a six week peroral therapy while no statistically significant differences between piracetam therapy at a dosage of 3X800 mg per day and placebo were found.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study